Omnicell (OMCL) Competitors $27.46 -0.51 (-1.81%) As of 10:41 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OMCL vs. MASI, AMN, WST, HSTM, MDRX, CRTX, IRTC, INSP, HNGE, and PRVAShould you be buying Omnicell stock or one of its competitors? The main competitors of Omnicell include Masimo (MASI), AMN Healthcare Services (AMN), West Pharmaceutical Services (WST), HealthStream (HSTM), Veradigm (MDRX), Cortexyme (CRTX), iRhythm Technologies (IRTC), Inspire Medical Systems (INSP), Hinge Health (HNGE), and Privia Health Group (PRVA). Omnicell vs. Its Competitors Masimo AMN Healthcare Services West Pharmaceutical Services HealthStream Veradigm Cortexyme iRhythm Technologies Inspire Medical Systems Hinge Health Privia Health Group Omnicell (NASDAQ:OMCL) and Masimo (NASDAQ:MASI) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership. Do insiders & institutionals hold more shares of OMCL or MASI? 97.7% of Omnicell shares are held by institutional investors. Comparatively, 86.0% of Masimo shares are held by institutional investors. 2.5% of Omnicell shares are held by insiders. Comparatively, 9.7% of Masimo shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more risk & volatility, OMCL or MASI? Omnicell has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, Masimo has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Is OMCL or MASI more profitable? Omnicell has a net margin of 1.87% compared to Masimo's net margin of -25.06%. Masimo's return on equity of 22.56% beat Omnicell's return on equity.Company Net Margins Return on Equity Return on Assets Omnicell1.87% 4.60% 2.56% Masimo -25.06%22.56%10.00% Does the media favor OMCL or MASI? In the previous week, Omnicell had 12 more articles in the media than Masimo. MarketBeat recorded 15 mentions for Omnicell and 3 mentions for Masimo. Masimo's average media sentiment score of 1.29 beat Omnicell's score of 0.77 indicating that Masimo is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omnicell 5 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Masimo 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer OMCL or MASI? Omnicell currently has a consensus price target of $44.83, indicating a potential upside of 63.24%. Masimo has a consensus price target of $191.60, indicating a potential upside of 22.17%. Given Omnicell's higher probable upside, equities research analysts clearly believe Omnicell is more favorable than Masimo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Omnicell 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57Masimo 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Which has stronger earnings and valuation, OMCL or MASI? Omnicell has higher earnings, but lower revenue than Masimo. Masimo is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmnicell$1.11B1.16$12.53M$0.4659.71Masimo$2.09B4.06-$304.90M-$9.17-17.10 SummaryMasimo beats Omnicell on 9 of the 16 factors compared between the two stocks. Get Omnicell News Delivered to You Automatically Sign up to receive the latest news and ratings for OMCL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OMCL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMCL vs. The Competition Export to ExcelMetricOmnicellMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.29B$1.97B$5.53B$9.43BDividend YieldN/AN/A3.80%4.06%P/E Ratio60.0234.1528.0919.94Price / Sales1.1615.83441.07101.39Price / Cash9.0853.8035.8457.94Price / Book1.028.788.215.70Net Income$12.53M-$62.39M$3.24B$257.97M7 Day Performance-4.27%0.27%1.81%2.84%1 Month Performance-2.85%10.80%8.42%12.02%1 Year Performance-0.20%8.15%30.64%19.23% Omnicell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMCLOmnicell3.4687 of 5 stars$27.47-1.8%$44.83+63.2%-2.4%$1.29B$1.11B60.023,670News CoverageAnalyst RevisionMASIMasimo4.2332 of 5 stars$162.45-3.1%$191.60+17.9%+45.3%$8.81B$2.09B-17.725,600AMNAMN Healthcare Services4.3573 of 5 stars$21.23-3.1%$32.08+51.1%-64.4%$812.68M$2.98B-4.902,968Positive NewsAnalyst RevisionWSTWest Pharmaceutical Services4.8142 of 5 stars$221.49-0.3%$320.00+44.5%-32.2%$15.91B$2.90B34.7710,600Positive NewsUpcoming EarningsHSTMHealthStream4.3552 of 5 stars$27.59-0.8%$31.50+14.2%-12.3%$842.05M$291.65M43.791,093Positive NewsMDRXVeradigm3.0024 of 5 stars$4.95+2.1%$13.00+162.6%-50.1%$535.91M$1.53B0.008,000Gap UpCRTXCortexymeN/A$1.61+0.6%N/A+127.0%$48.54MN/A-0.5455IRTCiRhythm Technologies1.174 of 5 stars$139.22-2.3%$138.60-0.4%+34.2%$4.44B$591.84M-44.342,000News CoverageAnalyst ForecastINSPInspire Medical Systems4.872 of 5 stars$127.11-1.1%$211.91+66.7%-11.9%$3.75B$802.80M58.581,246Positive NewsAnalyst ForecastHNGEHinge HealthN/A$43.09-7.6%$46.00+6.8%N/A$3.36BN/A0.001,514PRVAPrivia Health Group3.9092 of 5 stars$21.35-3.4%$27.77+30.1%+7.1%$2.60B$1.80B177.931,140 Related Companies and Tools Related Companies Masimo Competitors AMN Healthcare Services Competitors West Pharmaceutical Services Competitors HealthStream Competitors Veradigm Competitors Cortexyme Competitors iRhythm Technologies Competitors Inspire Medical Systems Competitors Hinge Health Competitors Privia Health Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OMCL) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredNew crypto laws coming. Will you win or lose?Washington’s first-ever “Crypto Week” could trigger a major Bitcoin surge — but one trader says don’t just buy...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omnicell, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omnicell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
